Andreas Zettl
Overview
Explore the profile of Andreas Zettl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1064
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weixler B, Ramser M, Warschkow R, Viehl C, Vaughan-Shaw P, Zettl A, et al.
Ann Surg Open
. 2023 Aug;
2(3):e084.
PMID: 37635823
Objectives: Mediation analysis to assess the protective impact of sentinel lymph node (SLN) mapping on prognosis and survival of patients with colon cancer through a more precise evaluation of the...
2.
Gerding H, Schlageter M, Zettl A, Goldblum D, Tappeiner C
Klin Monbl Augenheilkd
. 2023 May;
240(4):402-407.
PMID: 37164398
Background: Retrocorneal membranes (RCMs) may result from epithelial ingrowth, stromal keratocytic downgrowth, fibrous metaplasia of the corneal endothelium, or a combination of these processes. In an institutional case series, the...
3.
Marinucci M, Ercan C, Taha-Mehlitz S, Fourie L, Panebianco F, Bianco G, et al.
Front Oncol
. 2022 Jan;
11:781833.
PMID: 35083141
The use of patient-derived organoids (PDO) as a valuable alternative to models significantly increased over the last years in cancer research. The ability of PDOs to genetically resemble tumor heterogeneity...
4.
Ramser M, Warschkow R, Viehl C, Kettelhack C, Zettl A, Lobbes L, et al.
World J Surg
. 2021 Dec;
46(3):680-689.
PMID: 34958413
Background: According to the common tenet, tumour progression is a chronological process starting with lymphatic invasion. In this respect, the meaning of bone marrow micrometastases (BMM) in patients with lymph...
5.
Weixler B, da Cunha S, Warschkow R, Demartines N, Guller U, Zettl A, et al.
World J Surg
. 2021 Jan;
45(5):1526-1536.
PMID: 33512566
Background: Molecular lymph node workup with one-step nucleic acid amplification (OSNA) is a validated diagnostic adjunct in breast cancer and also appealing for colon cancer (CC) staging. This study, for...
6.
Vela V, Juskevicius D, Savic Prince S, Cathomas G, Dertinger S, Diebold J, et al.
Mod Pathol
. 2020 Aug;
34(2):371-379.
PMID: 32855441
Pulmonary lymphoid malignancies comprise various entities, 80% of them are pulmonary marginal zone B-cell lymphomas (PMZL). So far, little is known about point mutations in primary pulmonary lymphomas. We characterized...
7.
Manfredonia C, Muraro M, Hirt C, Mele V, Governa V, Papadimitropoulos A, et al.
Adv Biosyst
. 2020 Jul;
3(4):e1800300.
PMID: 32627426
Colorectal cancer (CRC) is a leading cause of cancer-related death. Conventional chemotherapeutic regimens have limited success rates, and a major challenge for the development of novel therapies is the lack...
8.
Kempf W, Torricelli R, Zettl A, Zimmermann A, Berisha A, Ghielmini M
Am J Dermatopathol
. 2019 Jul;
41(8):602-605.
PMID: 31335416
Large B-cell lymphomas include several subtypes. Recently, anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma has been delineated as a distinct entity involving mostly lymph nodes and rarely affecting extranodal sites....
9.
Savic S, Berezowska S, Eppenberger-Castori S, Cathomas G, Diebold J, Fleischmann A, et al.
Virchows Arch
. 2019 May;
475(1):67-76.
PMID: 31127385
With the approval of pembrolizumab for first- and second-line treatment of PD-L1+ non-small cell lung cancer (NSCLC), PD-L1 testing by immunohistochemistry (IHC) has become a necessity. However, the DAKO autostainer...
10.
Ankli B, Khanlari B, Pegios V, Zettl A, Daikeler T
Joint Bone Spine
. 2018 Jan;
85(5):645-646.
PMID: 29378265
No abstract available.